At 24 h after treatment, most combinations except with the lowest dose of MK-1775 (0.1 μM) also showed a tendency for a decrease in viability, but these did not reach statistical significance ( p = ns).
← all excerpts
Targeted Therapy of HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy between CDK4/6, PI3K and Sometimes FGFR Inhibitors, but Rarely between PARP and WEE1 Inhibitors.
1
—
—